Recent Company News

• 07:45 PM ET Feb 10, 2026
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 06:13 PM ET Feb 11, 2026
  

  Street Takeaways - CSL H1 Earnings (A$154.74, -8.70)

• 03:35 PM ET Feb 11, 2026
  

  CSL downgraded to neutral from buy at BofA (A$163.44, 0.00)

• 09:42 AM ET Feb 11, 2026
  

  FDA panel to meet 12-Mar to discuss flu vaccine strain composition for 26-27

• 08:47 AM ET Feb 11, 2026
  

  CSL downgraded to sector perform from outperform at RBC Capital Markets (A$163.44, 0.00)

• 10:58 PM ET Feb 10, 2026
  

  StreetAccount Summary: Australia and New Zealand Stocks reaching new 52-week highs/lows (35 total)

• 08:16 PM ET Feb 10, 2026
  

  Transcript Intelligence: CSL Q2 Earnings Guidance

• 08:15 PM ET Feb 10, 2026
  

  Transcript Intelligence: CSL Q2 Earnings Themes

• 08:15 PM ET Feb 10, 2026
  

  Transcript Intelligence: CSL Q2 Earnings Q&A